Company Foresee Pharmaceuticals Co., Ltd.

Equities

6576

TW0006576002

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per region

Ratings for Foresee Pharmaceuticals Co., Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
95 ^TWD	-0.11%		+1.50%	-1.25%

Apr. 01	Foresee Pharmaceuticals Receives Positive Recommendation from Data and Safety Monitoring Board to Continue the Casppian Study	CI
Mar. 28	Foresee Pharmaceuticals Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Foresee Pharmaceuticals Co., Ltd. is a Taiwan-based company mainly engaged in the research and development of new pharmaceuticals. The Company's main products include prostate cancer treatment product FP-001 and asthmatic/chronic obstructive pulmonary disease treatment product FP-025. It also engages in new pharmaceuticals clinic trial business.

TWD in Million	2022	Weight	2023	Weight	Delta
New Drug Development 100.0 %	302	100.0 %	195	100.0 %	-35.31%

TWD in Million	2022	Weight	2023	Weight	Delta
Taiwan 100.0 %	302	100.0 %	195	100.0 %	-35.31%

Managers	Title	Age	Since
Yu Hua Li FOU	Founder	-	15-07-08
Benjamin Chien CEO	Chief Executive Officer	-	13-02-07
Max Chan DFI	Director of Finance/CFO	56	19-10-06
Bassem Elmankabadi CTO	Chief Tech/Sci/R&D Officer	-	23-04-16
Sheng Lee Yi CTO	Chief Tech/Sci/R&D Officer	-	13-01-09
Mathieu Boudreau COO	Chief Operating Officer	-	-
Wenjin Yang CTO	Chief Tech/Sci/R&D Officer	-	15-09-20
Bill Miller LAW	General Counsel	-	21-05-18
David Lau PRN	Corporate Officer/Principal	-	-
Jiarong Zhuang AUD	Comptroller/Controller/Auditor	-	18-11-12

Members of the board	Title	Age	Since
George Lee BRD	Director/Board Member	73	15-08-02
Benjamin Chien CEO	Chief Executive Officer	-	13-02-07
Fu Shiow Yin BRD	Director/Board Member	-	16-03-30
Kun Hung Lai BRD	Director/Board Member	-	18-06-25
Wen Chi Lee BRD	Director/Board Member	-	16-03-30
Chia Lin Wang BRD	Director/Board Member	-	16-03-30
Chang Jen Yan BRD	Director/Board Member	-	13-01-09
Sheng Lee Yi CTO	Chief Tech/Sci/R&D Officer	-	13-01-09
Ben Liu BRD	Director/Board Member	-	23-05-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	135,817,300	90,710,142 ( 66.79 %)	0	66.79 %

Foresee Pharmaceuticals Co., Ltd.

9F-2, No.19-3, Sanchong Road Nangang District

115, Taipei

http://www.foreseepharma.com

address Foresee Pharmaceuticals Co., Ltd.(6576)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

95 TWD

Average target price

153 TWD

Spread / Average Target

+61.05%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
FORESEE PHARMACEUTICALS CO., LTD.	-1.25%	396M
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research